The policy restricts or prohibits pharmacies, prescription drug sales, drug paraphernalia, and products that mimic illegal drug effects from accessing Stripe's payment processing, with licensed pharmacies potentially eligible for restricted status subject to prior written approval.
This analysis describes what Stripe's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision requires pharmaceutical merchants and supplement sellers to evaluate whether their products fall within the restricted or prohibited category before onboarding, particularly given the broad framing of substances that mimic illegal drug effects, which may affect certain nutraceutical and hemp-derived product sellers.
Interpretive note: The scope of substances that mimic illegal drug effects is not precisely defined in the document, creating interpretive uncertainty for businesses selling legal psychoactive or nootropic products whose classification under this provision may depend on Stripe's internal determination.
Under this provision, pharmacies and businesses selling prescription drugs must obtain prior written approval from Stripe before processing payments, while sellers of drug paraphernalia and substances mimicking illegal drugs are prohibited entirely. Merchants in adjacent categories such as hemp-derived products or supplements should evaluate their product classification under this policy.
How other platforms handle this
You may not use Shopify's Services to sell, provide, or promote the following: Products that have been subject to government recalls; Health or medical products that make false claims; Supplements or health products that are not compliant with applicable regulations; Pharmaceuticals that require pre...
You may not use our Services for any illegal purpose or in violation of any laws or regulations. You may not use the Services to send money to sanctioned countries or individuals on government watchlists. You may not use the Services for gambling, illegal drugs, weapons, or any other prohibited acti...
Subject to your compliance with the terms of the Agreement (including, without limitation, these Terms and Taskrabbit's Acceptable Use Policy), Taskrabbit grants you a limited, non-exclusive, non-transferable and revocable license to (a) access and use the Platform (in the locations and territories ...
Monitoring
Stripe has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 10 platforms.
"Pharmacies and the sale of prescription drugs, as well as the sale of substances that mimic the effects of illegal drugs, sale of drug paraphernalia, and related items are among the categories restricted or prohibited from using Stripe's services.— Excerpt from Stripe's Stripe Restricted Businesses List
(1) REGULATORY LANDSCAPE: Prescription drug sales engage FDA regulations, the Drug Enforcement Administration's controlled substances scheduling, and state pharmacy board licensing requirements. Online pharmacy operations interact with the Ryan Haight Online Pharmacy Consumer Protection Act in the US. Hemp and CBD products occupy a regulatory grey area under the 2018 Farm Bill and FDA enforcement discretion policies. (2) GOVERNANCE EXPOSURE: Medium. The provision's reference to substances that mimic illegal drug effects creates interpretive uncertainty for businesses selling legal but psychoactive products including certain herbal supplements, kratom, and hemp-derived products, as Stripe's classification of these products may not align with the seller's own legal analysis. (3) JURISDICTION FLAGS: State pharmacy licensing requirements vary and create a multi-jurisdictional compliance matrix for online pharmacy operators. International pharmaceutical sales engage additional import/export restrictions and regulatory frameworks that interact with this provision. (4) CONTRACT AND VENDOR IMPLICATIONS: Marketplaces and e-commerce platforms hosting pharmaceutical or supplement merchants should include product category screening in vendor onboarding. Businesses should not assume that a product's legal status under applicable law determines its classification under Stripe's policy. (5) COMPLIANCE CONSIDERATIONS: Pharmaceutical merchants should document their licensing status and product regulatory classification before seeking Stripe approval. Businesses selling hemp or CBD products should contact Stripe to confirm category classification given the evolving regulatory environment.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 1 platform + weekly digest. Monitor: 10 platforms + same-day alerts. No credit card required.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
This provision requires pharmaceutical merchants and supplement sellers to evaluate whether their products fall within the restricted or prohibited category before onboarding, particularly given the broad framing of substances that mimic illegal drug effects, which may affect certain nutraceutical and hemp-derived product sellers.
Under this provision, pharmacies and businesses selling prescription drugs must obtain prior written approval from Stripe before processing payments, while sellers of drug paraphernalia and substances mimicking illegal drugs are prohibited entirely. Merchants in adjacent categories such as hemp-derived products or supplements should evaluate their product classification under this policy.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Stripe.